2024 Clinical and Scientific Advances in UTI

Friday, July 19, 2024, 3:00 PM - Sunday, July 21, 2024, 12:00 PM, Hyatt Regency Columbus, Columbus, OH


AMA PRA Category 1 Credits™ (11.75 hours), Non-Physician Attendance (11.75 hours)

  

To bring together medical professionals, biomedical scientists, government agencies, and industrial partners that are dedicated to eradicate the disease, broadly defined, of urinary tract infections. This includes the specific manifestations of infection in different patient populations and their sequelae, for the discovery of new diagnostic, therapeutic, and preventative approaches. As part of a long-term plan for managing urinary tract infection, we also have a training mission to recruit and support early career researchers and those not traditionally represented in medicine and research as they transition into the next generations of experts. The 2024 Clinical and Scientific Advances in Urinary Tract Infections (UTI) Conference will specifically focus on promoting the next generation of researchers and clinicians. As a result, the conference specifically strives to highlight the accomplishments of junior faculty members and trainees. Participation of junior faculty members and trainees is heavily encouraged, with possible travel support provided by the conference organizers for those with abstracts that are submitted and accepted.

 

Intended Audience

Any clinical providers who support patients with urinary tract infections (physicians, surgeons, physician extenders, nursing staff), veterinarians, as well as translational and discovery scientists with an interest in urinary tract infection pathogenesis.

1. Recognize the patient populations prone to urinary tract infections and factors involved in their increased susceptibility to infection.
2. Analyze practical considerations of caring for patients with urinary tract infections and implementing treatment.
3. Employ improvement changes in urinary tract infection management and prevention.
4. Alter the long-term sequelae of having had a urinary tract infection
5. Apply education on urinary tract infection pathology by merging the clinical impact with the research efforts in the laboratory.
6. Identify new approaches to prevent and treat urinary tract infection
7. Understand how co-morbidities and demographics may influence urinary tract infection susceptibility and severity

Pre-registration is preferred. However, walk-in registration will be available during the conference for the cost of the base registration fee as well as an additional $50. 

In support of improving patient care, this activity has been planned and implemented by Nationwide Children’s Hospital and the Urinary Tract Infection Global Alliance. Nationwide Children’s Hospital is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the American Nurses Credentialing Center (ANCC), and the Accreditation Council for Pharmacy Education (ACPE), to provide continuing medical education for the healthcare team. 


Credits
11.75 AMA PRA Category 1 CME Credit(s)™, 11.75 Non-Physician Attendance


Medicine
The Nationwide Children's Hospital designates this live activity for a maximum of 11.75 AMA PRA Category 1 Credit(s)^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Cancellation Policy

Cancellations received in writing no less than 20 days before the course will be refunded, less a 20% administrative fee. No refunds will be made on cancellations received after that date. Please send cancellation requests to [email protected].

Nationwide Children's Hospital reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred such as non-refundable airline tickets or hotel penalties.

Accessibility Statement
 
Nationwide Children's Hospital is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Conference Coordinator.

The block of rooms that was originally held for the conference attendees at the Hyatt Regency Columbus has reached its maximum capacity at this time. If you are in need of a place to stay, we have a room block available 7/18-7/21 at the Hilton Columbus Downtown, 402 N High St. Columbus, OH 43215. 

Please visit this booking link to book rooms in the block. If you prefer to call the hotel, use 1-800-HILTONS (1-800-445-8667). Please reference Group Code 95Y.

Reservations for the block will be available through Thursday, June 27, 2024 as that is the cut-off date. 

Please review parking information below: 

 

BELOW IS NO LONGER AVAILABLE. Please note! This information has remained here as a reference if you have booked your stay here.

A block of rooms has been held for conference attendees at the conference location, Hyatt Regency Columbus, 350 N High St. Columbus, OH 43215.

Please visit https://www.hyatt.com/en-US/group-booking/CMHRC/G-NWCU to book rooms in the block. If you prefer to call the hotel, please reference Group Code G-NWCU.

Reservations for the block will be available through June 21, 2024, or maximum capacity is reached. 

Click here for hotel parking information.

The Nationwide Children's Hospital® adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

Nationwide Children's Hospital adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Exhibit at this Event